Smart-Money SignalNeutral · 43/100— Insiders are net sellers over 90 days (-$4.6M, 33 sales vs 27 buys)
Revenue$389.0M
Net Income-$1.3B
EPS$-3.40
Market Cap$30.1B
Price Performance
Historical data including institutional events
Company Profile
S
Stéphane Bancel
CEO & Executive Director
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
